{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:18:18Z","timestamp":1784045898127,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10549-017-4483-2","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T05:36:20Z","timestamp":1504157780000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis"],"prefix":"10.1007","volume":"167","author":[{"given":"N. C.","family":"Verheuvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-2720","authenticated-orcid":false,"given":"A. C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. C. G.","family":"Tjan-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M. H.","family":"Roumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"4483_CR1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12253-009-9177-6","volume":"15","author":"O Coufal","year":"2009","unstructured":"Coufal O, Pavlik T, Fabian P et al (2009) Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? Pathol Oncol Res 15:733\u2013740","journal-title":"Pathol Oncol Res"},{"key":"4483_CR2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10147-007-0736-0","volume":"13","author":"N Wada","year":"2008","unstructured":"Wada N, Imoto S (2008) Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy. Int J Clin Oncol 13:24\u201332","journal-title":"Int J Clin Oncol"},{"key":"4483_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jamcollsurg.2008.10.029","volume":"208","author":"AS Gur","year":"2009","unstructured":"Gur AS, Unal B, Johnson R et al (2009) Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 208:229\u2013235","journal-title":"J Am Coll Surg"},{"key":"4483_CR4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0021-7697(07)79774-0","volume":"144","author":"C Coutant","year":"2007","unstructured":"Coutant C, Morel O, Antoine M et al (2007) Is axillary lymph node dissection always necessary in breast cancer patients with a positive sentinel node? J Chir (Paris) 144:492\u2013501","journal-title":"J Chir (Paris)"},{"key":"4483_CR5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjsurg.2006.06.016","volume":"192","author":"MH Cripe","year":"2006","unstructured":"Cripe MH, Beran LC, Liang WC et al (2006) The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Am J Surg 192:484\u2013487","journal-title":"Am J Surg"},{"key":"4483_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14:297\u2013305","journal-title":"Lancet Oncol"},{"key":"4483_CR7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.ejso.2014.07.041","volume":"40","author":"V Galimberti","year":"2014","unstructured":"Galimberti V, Manika A, Maisonneuve P et al (2014) Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease. Eur J Surg Oncol 40:1203\u20131208","journal-title":"Eur J Surg Oncol"},{"key":"4483_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569\u2013575","journal-title":"JAMA"},{"key":"4483_CR9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881\u2013888","journal-title":"Lancet Oncol"},{"key":"4483_CR10","doi-asserted-by":"crossref","unstructured":"Rutgers EJT, Donker M, Straver ME et al (2013) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: final analysis of the EORTC AMAROS trial. J Clin Oncol 31","DOI":"10.1200\/jco.2013.31.18_suppl.lba1001"},{"key":"4483_CR11","unstructured":"NABON national guideline breast cancer 2.0; Comprehensive Cancer Centre Netherlands (2012). www.oncoline.nl\/mammacarcinoom . Accessed 14 June 2016"},{"issue":"Suppl 5","key":"4483_CR12","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E et al (2015) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v8\u2013v30","journal-title":"Ann Oncol"},{"key":"4483_CR13","doi-asserted-by":"crossref","first-page":"b509","DOI":"10.1136\/bmj.b509","volume":"338","author":"N Murray","year":"2009","unstructured":"Murray N, Winstanley J, Bennett A et al (2009) Diagnosis and treatment of advanced breast cancer: summary of NICE guidance. BMJ 338:b509","journal-title":"BMJ"},{"key":"4483_CR14","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703\u20137720","journal-title":"J Clin Oncol"},{"key":"4483_CR15","unstructured":"National Breast and Ovarian Cancer Centre (NBOCC) Australia. Recommendations for use of Sentinel node biopsy in early (operable) breast cancer (June 2008); Cancer Australia 2011. www.canceraustralia.gov.au . Accessed 15 June 2016"},{"key":"4483_CR16","doi-asserted-by":"crossref","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines); Breast Cancer (2016). www.nccn.com . Accessed 14 June 2016","DOI":"10.6004\/jnccn.2016.0181"},{"key":"4483_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0748-7983(97)92885-7","volume":"23","author":"RM Roumen","year":"1997","unstructured":"Roumen RM, Valkenburg JG, Geuskens LM (1997) Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23:495\u2013502","journal-title":"Eur J Surg Oncol"},{"key":"4483_CR18","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/cncr.20934","volume":"103","author":"A Chagpar","year":"2005","unstructured":"Chagpar A, Middleton LP, Sahin AA et al (2005) Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103:1581\u20131586","journal-title":"Cancer"},{"key":"4483_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jamcollsurg.2007.01.064","volume":"205","author":"A Soran","year":"2007","unstructured":"Soran A, Falk J, Bonaventura M et al (2007) Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity? J Am Coll Surg 205:66\u201371","journal-title":"J Am Coll Surg"},{"key":"4483_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.surge.2011.10.006","volume":"11","author":"M Dordea","year":"2013","unstructured":"Dordea M, Colvin H, Cox P et al (2013) Clinical and histopathological factors affecting failed sentinel node localization in axillary staging for breast cancer. Surgeon 11:63\u201366","journal-title":"Surgeon"},{"key":"4483_CR21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","volume":"99","author":"A Goyal","year":"2006","unstructured":"Goyal A, Newcombe RG, Chhabra A et al (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer\u2013results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203\u2013208","journal-title":"Breast Cancer Res Treat"},{"key":"4483_CR22","first-page":"1232","volume":"44","author":"I Brenot-Rossi","year":"2003","unstructured":"Brenot-Rossi I, Houvenaeghel G, Jacquemier J et al (2003) Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? J Nucl Med 44:1232\u20131237","journal-title":"J Nucl Med"},{"key":"4483_CR23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1245\/ASO.2005.07.014","volume":"12","author":"C Rousseau","year":"2005","unstructured":"Rousseau C, Classe JM, Campion L et al (2005) The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancer. Ann Surg Oncol 12:533\u2013538","journal-title":"Ann Surg Oncol"},{"key":"4483_CR24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6600359","volume":"87","author":"PJ Tanis","year":"2002","unstructured":"Tanis PJ, Nieweg OE, Valdes Olmos RA et al (2002) Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 87:705\u2013710","journal-title":"Br J Cancer"},{"key":"4483_CR25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1245\/s10434-012-2625-7","volume":"20","author":"AJ Maaskant-Braat","year":"2013","unstructured":"Maaskant-Braat AJ, Roumen RM, Voogd AC et al (2013) Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol 20:620\u2013626","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"4483_CR26","doi-asserted-by":"crossref","first-page":"S529","DOI":"10.1245\/s10434-015-4787-6","volume":"22","author":"G Vugts","year":"2015","unstructured":"Vugts G, Maaskant-Braat AJ, Voogd AC et al (2015) Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer. Ann Surg Oncol 22(Suppl 3):S529\u2013S535","journal-title":"Ann Surg Oncol"},{"key":"4483_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","volume":"99","author":"A Goyal","year":"2006","unstructured":"Goyal A, Newcombe RG, Chhabra A et al (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer\u2013results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203\u2013208","journal-title":"Breast Cancer Res Treat"},{"key":"4483_CR28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00000658-200105000-00012","volume":"233","author":"KM McMasters","year":"2001","unstructured":"McMasters KM, Wong SL, Martin RC et al (2001) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233:676\u2013687","journal-title":"Ann Surg"},{"key":"4483_CR29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/s10434-009-0403-y","volume":"16","author":"EM Heuts","year":"2009","unstructured":"Heuts EM, van der Ent FW, van der Pol HA et al (2009) Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer. Ann Surg Oncol 16:1156\u20131163","journal-title":"Ann Surg Oncol"},{"key":"4483_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.breast.2007.08.008","volume":"17","author":"K Straalman","year":"2008","unstructured":"Straalman K, Kristoffersen US, Galatius H et al (2008) Factors influencing sentinel lymph node identification failure in breast cancer surgery. Breast 17:167\u2013171","journal-title":"Breast"},{"key":"4483_CR31","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.ejso.2016.05.007","volume":"42","author":"NC Verheuvel","year":"2016","unstructured":"Verheuvel NC, Voogd AC, Tjan-Heijnen VC, et al (2016) Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients. Eur J Surg Oncol 42:1162\u20131168","journal-title":"Eur J Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4483-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T20:06:55Z","timestamp":1570046815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4483-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4483-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]}}}